These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
602 related articles for article (PubMed ID: 34021148)
101. High IL-6/IFN-γ ratio could be associated with severe disease in COVID-19 patients. Lagunas-Rangel FA; Chávez-Valencia V J Med Virol; 2020 Oct; 92(10):1789-1790. PubMed ID: 32297995 [No Abstract] [Full Text] [Related]
102. Hypoxia acts as an environmental cue for the human tissue-resident memory T cell differentiation program. Hasan F; Chiu Y; Shaw RM; Wang J; Yee C JCI Insight; 2021 May; 6(10):. PubMed ID: 34027895 [TBL] [Abstract][Full Text] [Related]
103. Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines. Cao Y; Yisimayi A; Bai Y; Huang W; Li X; Zhang Z; Yuan T; An R; Wang J; Xiao T; Du S; Ma W; Song L; Li Y; Li X; Song W; Wu J; Liu S; Li X; Zhang Y; Su B; Guo X; Wei Y; Gao C; Zhang N; Zhang Y; Dou Y; Xu X; Shi R; Lu B; Jin R; Ma Y; Qin C; Wang Y; Feng Y; Xiao J; Xie XS Cell Res; 2021 Jul; 31(7):732-741. PubMed ID: 34021265 [TBL] [Abstract][Full Text] [Related]
104. Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Le Vu S; Jones G; Anna F; Rose T; Richard JB; Bernard-Stoecklin S; Goyard S; Demeret C; Helynck O; Escriou N; Gransagne M; Petres S; Robin C; Monnet V; Perrin de Facci L; Ungeheuer MN; Léon L; Guillois Y; Filleul L; Charneau P; Lévy-Bruhl D; van der Werf S; Noel H Nat Commun; 2021 May; 12(1):3025. PubMed ID: 34021152 [TBL] [Abstract][Full Text] [Related]
105. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets. Dugan HL; Stamper CT; Li L; Changrob S; Asby NW; Halfmann PJ; Zheng NY; Huang M; Shaw DG; Cobb MS; Erickson SA; Guthmiller JJ; Stovicek O; Wang J; Winkler ES; Madariaga ML; Shanmugarajah K; Jansen MO; Amanat F; Stewart I; Utset HA; Huang J; Nelson CA; Dai YN; Hall PD; Jedrzejczak RP; Joachimiak A; Krammer F; Diamond MS; Fremont DH; Kawaoka Y; Wilson PC Immunity; 2021 Jun; 54(6):1290-1303.e7. PubMed ID: 34022127 [TBL] [Abstract][Full Text] [Related]
106. Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19. Lowery SA; Sariol A; Perlman S Cell Host Microbe; 2021 Jul; 29(7):1052-1062. PubMed ID: 34022154 [TBL] [Abstract][Full Text] [Related]
116. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights. Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ Interdiscip Sci; 2021 Jun; 13(2):344-347. PubMed ID: 34021862 [TBL] [Abstract][Full Text] [Related]
117. Immune response to SARS-CoV-2 variants of concern in vaccinated individuals. Becker M; Dulovic A; Junker D; Ruetalo N; Kaiser PD; Pinilla YT; Heinzel C; Haering J; Traenkle B; Wagner TR; Layer M; Mehrlaender M; Mirakaj V; Held J; Planatscher H; Schenke-Layland K; Krause G; Strengert M; Bakchoul T; Althaus K; Fendel R; Kreidenweiss A; Koeppen M; Rothbauer U; Schindler M; Schneiderhan-Marra N Nat Commun; 2021 May; 12(1):3109. PubMed ID: 34035301 [TBL] [Abstract][Full Text] [Related]
118. SARS-CoV-2 and other human coronavirus show genome patterns previously associated to reduced viral recognition and altered immune response. Franzo G Sci Rep; 2021 May; 11(1):10696. PubMed ID: 34021237 [TBL] [Abstract][Full Text] [Related]
119. Scientists zero in on long-sought marker of COVID-vaccine efficacy. Mallapaty S Nature; 2021 May; ():. PubMed ID: 34021284 [No Abstract] [Full Text] [Related]